SynBiotic SE
FSX:SBX.DE
5.86 (EUR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q2 | 2020 Q4 | 2020 Q2 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.019 | 0.049 | 5.396 | 0.05 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0.019 | 0.049 | 5.396 | 0.05 |
| Gross Profit Ratio
| 0 | 0 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0 | 0 | 1.172 | 0.434 | 6.157 | 0.147 |
| Other Expenses
| 0 | 0 | 0.013 | 0 | 0 | 0 |
| Operating Expenses
| 0 | 0 | 1.159 | 0.434 | 6.157 | 0.147 |
| Operating Income
| 0 | 0 | -1.247 | -0.491 | -0.761 | -0.097 |
| Operating Income Ratio
| 0 | 0 | -67.363 | -10.06 | -0.141 | -1.949 |
| Total Other Income Expenses Net
| 0 | 0 | -0.04 | 0.053 | -0 | 0 |
| Income Before Tax
| 0 | 0 | -1.288 | -0.438 | -0.761 | -0.097 |
| Income Before Tax Ratio
| 0 | 0 | -69.548 | -8.974 | -0.141 | -1.949 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0.022 | 0 |
| Net Income
| 0 | 0 | -1.288 | -0.438 | -0.783 | -0.097 |
| Net Income Ratio
| 0 | 0 | -69.548 | -8.974 | -0.145 | -1.949 |
| EPS
| 0 | 0 | -0.3 | -0.16 | -0.29 | -0.042 |
| EPS Diluted
| 0 | 0 | -0.3 | -0.16 | -0.29 | -0.042 |
| EBITDA
| 0 | 0 | -1.141 | -0.385 | -0.761 | -0.097 |
| EBITDA Ratio
| 0 | 0 | -61.612 | -7.89 | -0.141 | -1.949 |